Artemotil

Drug Profile

Artemotil

Alternative Names: Artecef; Arteether; Artether; Beta-arteether; Betamotil; SM 227; β-arteether

Latest Information Update: 30 Mar 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Shanghai Institute of Materia Medica
  • Developer Brocacef Holding
  • Class Antimalarials; Artemisinins; Small molecules
  • Mechanism of Action Free radical stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Falciparum malaria
  • Discontinued Toxoplasmosis

Most Recent Events

  • 30 Mar 2015 Launched for Falciparum malaria in India (IM) before March 2015
  • 30 Mar 2015 No recent reports on development identified - Registered for Falciparum malaria in France, Myanmar, Thailand, Niger, Nigeria, Sudan and Pakistan (IM)
  • 14 Aug 2002 A clinical study has been added to the pharmacokinetics section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top